Amplify Therapeutics ApS — Credit Rating and Financial Key Figures

CVR number: 43803999
Ole Maaløes Vej 3, 2200 København N
Free credit report Annual report

Income statement (kDKK)

2023
2024
Fiscal period length1212
Net sales
Gross profit-1 558.70-4 961.50
Employee benefit expenses- 825.44-3 318.95
EBIT-2 384.14-8 280.45
Other financial income2.8016.88
Other financial expenses-97.70- 513.89
Pre-tax profit-2 479.04-8 777.46
Income taxes526.321 582.60
Net earnings-1 952.72-7 194.85

Assets (kDKK)

2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables278.46163.84
Current deferred tax assets526.321 582.60
Short term receivables total804.791 746.44
Cash and bank deposits1 824.904 198.29
Cash and cash equivalents1 824.904 198.29
Balance sheet total (assets)2 629.685 944.73

Equity and liabilities (kDKK)

2023
2024
Share capital40.0040.00
Retained earnings-1 952.72
Profit of the financial year-1 952.72-7 194.85
Shareholders equity total-1 912.72-9 107.57
Non-current deferred tax liabilities4 097.6414 597.42
Non-current liabilities total4 097.6414 597.42
Current loans from credit institutions17.15
Current trade creditors257.0880.01
Other non-interest bearing current liabilities121.02357.73
Accruals and deferred income66.67
Current liabilities total444.76454.88
Balance sheet total (liabilities)2 629.685 944.73
CreditReports API
  • Company information
  • Financial data
  • Credit risk data
  • All 400,000+ Danish companies

Read more about CreditReports API
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.

Full version